ebook Munafa Stock Market Course + Intraday & FNO calls  

       

SUPN announcements Supernus Pharmaceuticals, Inc. announcements and dividends declared USA

Supernus Pharmaceuticals, Inc. Complete list of announcements declared & dividend announcements by Supernus Pharmaceuticals, Inc. SUPN

Supernus Pharmaceuticals, Inc. SUPN listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Supernus Pharmaceuticals, Inc. SUPN

Supernus Pharmaceuticals (SUPN) Lags Q4 Earnings Estimates
Supernus Pharmaceuticals (SUPN) came out with quarterly earnings of [CO].02 per share, missing the Zacks Consensus Estimate of [CO].41 per share. This compares to earnings of [CO].43 per share a year ago. These figures are adjusted for
Announcement as on 27 February 2024

Supernus Pharmaceuticals (SUPN) Lags Q4 Earnings Estimates
Supernus Pharmaceuticals (SUPN) came out with quarterly earnings of [CO].02 per share, missing the Zacks Consensus Estimate of [CO].41 per share. This compares to earnings of [CO].43 per share a year ago. These figures are adjusted for
Announcement as on 27 February 2024

Supernus Pharmaceuticals (SUPN) Reports Q3 Loss, Tops Revenue Estimates
Supernus Pharmaceuticals (SUPN) came out with a quarterly loss of [CO].29 per share versus the Zacks Consensus Estimate of [CO].13. This compares to earnings of [CO].03 per share a year ago. These figures are adjusted for non-recurring
Announcement as on 09 November 2023

Supernus Pharmaceuticals (SUPN) Reports Q3 Loss, Tops Revenue Estimates
Supernus Pharmaceuticals (SUPN) came out with a quarterly loss of [CO].29 per share versus the Zacks Consensus Estimate of [CO].13. This compares to earnings of [CO].03 per share a year ago. These figures are adjusted for non-recurring
Announcement as on 09 November 2023

Announcements by Supernus Pharmaceuticals, Inc. first page |

SUPN Supernus Pharmaceuticals, Inc. current price & indicator signals

Moving Averages for Supernus Pharmaceuticals, Inc.

  • 5Day Average: 45.62
  • 12Day Average: 45.45
  • 20Day Average: 45.3
  • 50Day Average: 48.33
  • 100Day Average: 45.29
  • 150Day Average: 40.98
  • 200Day Average: 38.69

SUPN Indicators & signals

Indicator MACD (12,26,9)

45.66, 46.41, -0.99
Indicator MACD is in negative zone

Indicator ADX (14)

0, 20, 20
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 43
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of SUPN Supernus Pharmaceuticals, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
09 Tue Dec 2025 45.42 45.36 to 47.24 -3.69% 0.86 times
08 Mon Dec 2025 47.16 45.75 to 47.26 3.24% 1.35 times
05 Fri Dec 2025 45.68 44.51 to 45.88 1.29% 0.67 times
04 Thu Dec 2025 45.10 44.28 to 45.10 0.76% 0.72 times
03 Wed Dec 2025 44.76 44.21 to 45.07 1.45% 0.77 times
02 Tue Dec 2025 44.12 44.09 to 44.90 -1.3% 0.91 times
01 Mon Dec 2025 44.70 44.65 to 45.58 -1.95% 0.83 times
28 Fri Nov 2025 45.59 45.53 to 46.57 -1.45% 0.63 times
26 Wed Nov 2025 46.26 45.72 to 47.00 0.39% 1.45 times
25 Tue Nov 2025 46.08 45.16 to 46.79 2.06% 1.46 times
24 Mon Nov 2025 45.15 45.00 to 46.00 -0.38% 1.2 times
21 Fri Nov 2025 45.32 44.37 to 46.09 1.18% 0.93 times

Videos related to: SUPN announcements Supernus Pharmaceuticals, Inc. announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

SUPN announcements Supernus Pharmaceuticals, Inc. announcements and dividends declared USA

 

Back to top